Bendamustine Side Effects
What was Your Bendamustine Experience? Bendamustine Side Effects
Post Side Effect
Ask Community
Compare Side Effects
Recent Bendamustine Side Effect Reports
Bendamustine Side Effects Report #5701519-3
Physician from UNITED STATES reported Bendamustine side effect on Mar 26, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: hypercalcaemia, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5729657-X
Bendamustine side effect was reported by a Health Professional from GERMANY on Apr 02, 2008. Female patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: aphasia
, brain oedema, cerebral infarction, cerebrovascular accident. Bendamustine dosage: 80 MG/M2, CYCLIC QD INTRAVENOUS. During the same period patient was treated with RITUXIMAB. Patient was hospitalized.
Physician from UNITED STATES reported Bendamustine side effect on Mar 26, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: hypercalcaemia, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5729657-X
Bendamustine side effect was reported by a Health Professional from GERMANY on Apr 02, 2008. Female patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: aphasia
, brain oedema, cerebral infarction, cerebrovascular accident. Bendamustine dosage: 80 MG/M2, CYCLIC QD INTRAVENOUS. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. View More
View All Bendamustine FDA Adverse ReportsGo to the top of the page
Bendamustine Adverse Effect Reports (FDA)
Physician from UNITED STATES reported Bendamustine side effect on May 15, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chills, dehydration, fatigue, herpes simplex, hydronephrosis, pancytopenia, pleural effusion. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #5794307-3
Bendamustine side effect was reported by a Physician from UNITED STATES on June 19, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chills, dehydration, dyspnoea, fatigue, herpes simplex, hydronephrosis, pancytopenia. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #5801973-2
Physician from UNITED STATES reported Bendamustine side effect on June 19, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chest x-ray abnormal, dehydration, effusion, herpes simplex, hydronephrosis, infection , pancytopenia. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #5802177-X
Bendamustine side effect was reported by a Physician from JAPAN on June 19, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: dyspnoea. Bendamustine dosage: 120 MG/M2 CYCLE ONE QD INTRAVENOUS DRIP. Patient was hospitalized.
Bendamustine Side Effects Report #5807516-1
Pharmacist from UNITED STATES reported Bendamustine side effect on July 09, 2008. Male patient, 59 years of age, weighting 185.2 lb, was diagnosed with neoplasm malignant and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bendamustine dosage: 100 MG EVERY DAY IV. Patient was hospitalized.
Bendamustine Side Effects Report #5827865-0
Bendamustine side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: asthma, reversible airways obstruction. Bendamustine dosage: 120 MG/M2 CYCLE ONE QD INTRAVENOUS DRIP. Patient was hospitalized.
Bendamustine Side Effects Report #5891527-4
Health Professional from GERMANY reported Bendamustine side effect on Sept 08, 2008. Female patient, 66 years of age, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: agranulocytosis, herpes zoster, jc virus infection, progressive multifocal leukoencephalopathy. Bendamustine dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died.
Bendamustine Side Effects Report #5892463-X
Bendamustine side effect was reported by a Physician from UNITED STATES on Sept 12, 2008. Male patient, 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, hypotension, international normalised ratio increased, lobar pneumonia, lymphadenopathy. Bendamustine dosage: 182 MG DAYS 1 AND 4, Q 28 DAYS INTRAVENOUS. During the same period patient was treated with RITUXIMAB, BORTEZOMIB, NORVASC, LISINOPRIL, ZOCOR, RYTHMOL, LOPRESSOR, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #5912988-8
Health Professional from UNITED STATES reported Bendamustine side effect on Sept 12, 2008. Male patient, 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: acute respiratory failure, adrenal adenoma, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, constipation, diverticulum, hypotension. Bendamustine dosage: 182 MG DAYS 1 AND 4, Q 28 DAYS INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, NORVASC, LISINOPRIL, ZOCOR, RYTHMOL, LOPRESSOR, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #5943943-X
Bendamustine side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2008. Male patient, 71 years of age, weighting 204.0 lb, was diagnosed with multiple myeloma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, fatigue, heart rate irregular, pallor, ventricular arrhythmia. Bendamustine dosage: 75 MG/M2 DAYS 1 AND 2 OF 28-DAY CYCLE INTRAVENOUS. During the same period patient was treated with REVLIMID, COUMADIN, PROCARDIA, LEXAPRO, PRANDIN, XANAX. Patient was hospitalized.
Bendamustine Side Effects Report #5948346-X
Pharmacist from UNITED STATES reported Bendamustine side effect on Nov 10, 2008. Male patient, weighting 167.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Bendamustine dosage: unknown. Patient was hospitalized.
Bendamustine Side Effects Report #5977649-8
Bendamustine side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: disease progression, hypercalcaemia, non-hodgkin's lymphoma, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5981489-3
Physician from UNITED STATES reported Bendamustine side effect on Nov 26, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: hypercalcaemia, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5988789-1
Bendamustine side effect was reported by a Physician from JAPAN on Nov 06, 2008. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, infection, pyrexia, viral infection . Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with BANDAMUSTINE. Patient was hospitalized.
Bendamustine Side Effects Report #5993028-1
Physician from UNITED STATES reported Bendamustine side effect on Dec 03, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood magnesium decreased, dehydration, diarrhoea, dyspnoea, hypercalcaemia, nausea. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, RHINOCORT, ALLEGRA, ALBUTEROL, FLOVENT, MAXZIDE, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #5994505-X
Bendamustine side effect was reported by a Physician from JAPAN on Sept 19, 2008. Female patient, 41 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomegaly, electrocardiogram st segment abnormal, palpitations, pericardial effusion, pleural effusion, sinus tachycardia, wheezing. Bendamustine dosage: 120 MG/M2 FIRST THRU SIXTH CYCLE QD INTRAVENOUS DRIP. Patient was hospitalized.
Bendamustine Side Effects Report #6005061-4
Physician from UNITED STATES reported Bendamustine side effect on Dec 08, 2008. Male patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: haemolytic anaemia, rheumatoid arthritis. Bendamustine dosage: unknown. Patient was hospitalized.
Bendamustine Side Effects Report #6005133-4
Bendamustine side effect was reported by a Physician from UNITED STATES on Dec 05, 2008. Male patient, 71 years of age, weighting 204.0 lb, was diagnosed with multiple myeloma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea exertional, ejection fraction decreased, electrocardiogram qt prolonged, fatigue, heart rate irregular, pallor, ventricular arrhythmia, ventricular extrasystoles. Bendamustine dosage: 75 MG/M2 DAYS 1 AND 2 OF 28-DAY CYCLE INTRAVENOUS. During the same period patient was treated with REVLIMID, COUMADIN, PROCARDIA, LEXAPRO, PRANDIN, XANAX. Patient was hospitalized.
Bendamustine Side Effects Report #6010895-6
Physician from UNITED STATES reported Bendamustine side effect on Dec 10, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood magnesium decreased, confusional state, dehydration, diarrhoea, dyspnoea, epistaxis, hepatomegaly. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, RHINOCORT, ALLEGRA, ALBUTEROL, FLOVENT, MAXZIDE, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #6024191-4
Bendamustine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2008. Female patient, 62 years of age, weighting 175.5 lb, was diagnosed with b-cell lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alopecia, anaemia, aortic arteriosclerosis, arteriosclerosis coronary artery, ascites, bacterial sepsis, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased. Bendamustine dosage: 90 MG/M2 DAYS 1 + 4 INTRAVENOUS. During the same period patient was treated with BORTEZOMIB, RITUXAN, ZAROXOLYN, POTASSIUM CHLORIDE, MYLANTA, FLONASE, METOCLOPRAMIDE, LORTAB. Patient was hospitalized. Patient died on 11/10/2008.
Bendamustine Side Effects Report #6032681-3
Physician from UNITED STATES reported Bendamustine side effect on Dec 30, 2008. Male patient, 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, fluid intake reduced, hypophagia, ulcer haemorrhage, upper gastrointestinal haemorrhage. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #6052841-5
Bendamustine side effect was reported by a Physician from UNITED STATES on Jan 15, 2009. Male patient, 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, gastrointestinal ulcer haemorrhage, haematemesis, hypophagia, hypotension. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, CYMBALTA, LYRICA, MORPHINE, ZOLPIDEM, BACTRIM DS. Patient was hospitalized.
Bendamustine Side Effects Report #6058086-7
Physician from UNITED STATES reported Bendamustine side effect on Jan 21, 2009. Male patient, 55 years of age, weighting 211.6 lb, was diagnosed with lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, hypotension, loss of consciousness, neutrophil count decreased, syncope. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, CYMBALTA, LYRICA, MORPHINE, ZOLPIDEM, BACTRIM DS. Patient was hospitalized.
Bendamustine Side Effects Report #6071764-9
Bendamustine side effect was reported by a Physician from JAPAN on Nov 12, 2008. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aspartate aminotransferase increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood lactate dehydrogenase increased, blood urea increased, brain natriuretic peptide increased, c-reactive protein increased, cough. Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MECOBALAMIN, ADENOSINE, REBAMIPIDE. Patient was hospitalized.
Bendamustine Side Effects Report #6090773-7
Physician from UNITED STATES reported Bendamustine side effect on Feb 17, 2009. Male patient, 63 years of age, weighting 175.9 lb, was diagnosed with lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: diarrhoea, hypotension, oedema peripheral, tumour lysis syndrome. Bendamustine dosage: 180 MG QD INTRAVENOUS. During the same period patient was treated with BORTEZOMIB, RITUXIMAB, ZOFRAN, COMPAZINE, TYLENOL, MEPRAZOL, SIMVASTATIN. Patient was hospitalized.
Bendamustine Side Effects Report #6091153-0
Bendamustine side effect was reported by a Physician from JAPAN on Feb 06, 2009. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cough, dizziness, heart rate increased, immune system disorder, malaise, oropharyngeal pain, pyrexia, viral infection . Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MECOBALAMIN, ADENOSINE, REBAMIPIDE. Patient was hospitalized.
Bendamustine Side Effects Report #6097316-2
Pharmacist from UNITED STATES reported Bendamustine side effect on Feb 26, 2009. Male patient, 45 years of age, was treated with Bendamustine. After drug was administered, patient experienced the following side effects: injection site pain. Bendamustine dosage: unknown.
Bendamustine Side Effects Report #6104696-8
Bendamustine side effect was reported by a Physician from UNITED STATES on Feb 24, 2009. Female patient, 52 years of age, weighting 165.0 lb, was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, biopsy bone marrow abnormal, cough, fatigue, lymphadenopathy, malaise, myalgia, neutrophil count decreased. Bendamustine dosage: 70 MG/M2 DAY 2, EVERY 35 DAYS X 5 CYCLES INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, METFORMIN, SIMVASTATIN, LASIX, NEXIUM, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #6106887-9
Physician from UNITED STATES reported Bendamustine side effect on Feb 26, 2009. Male patient, 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: atelectasis, dehydration, heart rate increased, lung infiltration, lymphoma, malignant neoplasm progression, pleural effusion. Bendamustine dosage: 90 MG/M2 D1 ND D2 Q35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #6106888-0
Bendamustine side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2009. Female patient, 52 years of age, weighting 165.0 lb, was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, cough, fatigue, lymphadenopathy, myalgia, neutrophil count decreased, nocardiosis, organising pneumonia. Bendamustine dosage: 70 MG/M2 DAY 2, EVERY 35 DAYS X 5 CYCLES INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, METFORMIN, SIMVASTATIN, LASIX, NEXIUM, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #6112025-9
Physician from UNITED STATES reported Bendamustine side effect on Mar 04, 2009. Male patient, 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, anaemia, atelectasis, dehydration, hydronephrosis, lymphadenopathy, lymphoma, myocardial ischaemia. Bendamustine dosage: 90 MG/M2 D1 AND D2 Q35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #4668602-5
Bendamustine side effect was reported by a Physician from on Nov 03, 2004. Male patient, 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, metastases to bone and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: jaw disorder, osteonecrosis. Bendamustine dosage: 75 MG, QMO. During the same period patient was treated with PREDNISOLONE, ZOMETA.
Bendamustine Side Effects Report #5039466-5
Physician from GERMANY reported Bendamustine side effect on Nov 03, 2004. Male patient, 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, multiple myeloma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: dental treatment, gingival ulceration, osteonecrosis , periodontitis. Bendamustine dosage: 75 MG, QMO. During the same period patient was treated with PREDNISOLONE, ZOMETA.
Go to the top of the page
c
Bendamustine Side Effects Report #5756661-8
Physician from UNITED STATES reported Bendamustine side effect on May 15, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chills, dehydration, fatigue, herpes simplex
, hydronephrosis, pancytopenia, pleural effusion. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized. Bendamustine Side Effects Report #5794307-3
Bendamustine side effect was reported by a Physician from UNITED STATES on June 19, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chills, dehydration, dyspnoea, fatigue, herpes simplex
, hydronephrosis, pancytopenia. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized. Bendamustine Side Effects Report #5801973-2
Physician from UNITED STATES reported Bendamustine side effect on June 19, 2008. Male patient, 68 years of age, weighting 187.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: ascites, azotaemia, chest x-ray abnormal, dehydration, effusion, herpes simplex
, hydronephrosis, infection , pancytopenia. Bendamustine dosage: 100 MG D1, D2 Q 35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, DIFLUCAN, ACYCLOVIR, LASIX, POTASSIUM CHLORIDE, METAMUCIL, LEVAQUIN. Patient was hospitalized. Bendamustine Side Effects Report #5802177-X
Bendamustine side effect was reported by a Physician from JAPAN on June 19, 2008. Female patient was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: dyspnoea. Bendamustine dosage: 120 MG/M2 CYCLE ONE QD INTRAVENOUS DRIP. Patient was hospitalized.
Bendamustine Side Effects Report #5807516-1
Pharmacist from UNITED STATES reported Bendamustine side effect on July 09, 2008. Male patient, 59 years of age, weighting 185.2 lb, was diagnosed with neoplasm malignant and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: febrile neutropenia. Bendamustine dosage: 100 MG EVERY DAY IV. Patient was hospitalized.
Bendamustine Side Effects Report #5827865-0
Bendamustine side effect was reported by a Physician from JAPAN on July 01, 2008. Male patient, 58 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: asthma
, reversible airways obstruction. Bendamustine dosage: 120 MG/M2 CYCLE ONE QD INTRAVENOUS DRIP. Patient was hospitalized. Bendamustine Side Effects Report #5891527-4
Health Professional from GERMANY reported Bendamustine side effect on Sept 08, 2008. Female patient, 66 years of age, was diagnosed with non-hodgkin's lymphoma recurrent and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: agranulocytosis, herpes zoster, jc virus infection, progressive multifocal leukoencephalopathy. Bendamustine dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died.
Bendamustine Side Effects Report #5892463-X
Bendamustine side effect was reported by a Physician from UNITED STATES on Sept 12, 2008. Male patient, 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: acute respiratory failure, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, hypotension, international normalised ratio increased, lobar pneumonia, lymphadenopathy. Bendamustine dosage: 182 MG DAYS 1 AND 4, Q 28 DAYS INTRAVENOUS. During the same period patient was treated with RITUXIMAB, BORTEZOMIB, NORVASC, LISINOPRIL, ZOCOR, RYTHMOL, LOPRESSOR, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #5912988-8
Health Professional from UNITED STATES reported Bendamustine side effect on Sept 12, 2008. Male patient, 84 years of age, weighting 200.6 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: acute respiratory failure, adrenal adenoma, anaemia, arteriosclerosis coronary artery, atelectasis, cardiac failure congestive, constipation
, diverticulum, hypotension. Bendamustine dosage: 182 MG DAYS 1 AND 4, Q 28 DAYS INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, NORVASC, LISINOPRIL, ZOCOR, RYTHMOL, LOPRESSOR, COUMADIN. Patient was hospitalized. Bendamustine Side Effects Report #5943943-X
Bendamustine side effect was reported by a Health Professional from UNITED STATES on Oct 27, 2008. Male patient, 71 years of age, weighting 204.0 lb, was diagnosed with multiple myeloma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: electrocardiogram qt prolonged, fatigue, heart rate irregular, pallor, ventricular arrhythmia. Bendamustine dosage: 75 MG/M2 DAYS 1 AND 2 OF 28-DAY CYCLE INTRAVENOUS. During the same period patient was treated with REVLIMID, COUMADIN, PROCARDIA, LEXAPRO, PRANDIN, XANAX. Patient was hospitalized. Bendamustine Side Effects Report #5948346-X
Pharmacist from UNITED STATES reported Bendamustine side effect on Nov 10, 2008. Male patient, weighting 167.0 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Bendamustine dosage: unknown. Patient was hospitalized.
Bendamustine Side Effects Report #5977649-8
Bendamustine side effect was reported by a Physician from UNITED STATES on Nov 20, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: disease progression, hypercalcaemia, non-hodgkin's lymphoma, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5981489-3
Physician from UNITED STATES reported Bendamustine side effect on Nov 26, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: hypercalcaemia, thrombocytopenia. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized.
Bendamustine Side Effects Report #5988789-1
Bendamustine side effect was reported by a Physician from JAPAN on Nov 06, 2008. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, infection
, pyrexia, viral infection . Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with BANDAMUSTINE. Patient was hospitalized. Bendamustine Side Effects Report #5993028-1
Physician from UNITED STATES reported Bendamustine side effect on Dec 03, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: atelectasis, blood albumin decreased, blood alkaline phosphatase increased, blood magnesium decreased, dehydration, diarrhoea, dyspnoea, hypercalcaemia, nausea
. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, RHINOCORT, ALLEGRA, ALBUTEROL, FLOVENT, MAXZIDE, COUMADIN. Patient was hospitalized. Bendamustine Side Effects Report #5994505-X
Bendamustine side effect was reported by a Physician from JAPAN on Sept 19, 2008. Female patient, 41 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: cardiac failure congestive, cardiomegaly, electrocardiogram st segment abnormal, palpitations, pericardial effusion, pleural effusion, sinus tachycardia, wheezing. Bendamustine dosage: 120 MG/M2 FIRST THRU SIXTH CYCLE QD INTRAVENOUS DRIP. Patient was hospitalized.
Bendamustine Side Effects Report #6005061-4
Physician from UNITED STATES reported Bendamustine side effect on Dec 08, 2008. Male patient, 63 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: haemolytic anaemia, rheumatoid arthritis
. Bendamustine dosage: unknown. Patient was hospitalized. Bendamustine Side Effects Report #6005133-4
Bendamustine side effect was reported by a Physician from UNITED STATES on Dec 05, 2008. Male patient, 71 years of age, weighting 204.0 lb, was diagnosed with multiple myeloma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: chest pain , dyspnoea exertional, ejection fraction decreased, electrocardiogram qt prolonged, fatigue, heart rate irregular, pallor, ventricular arrhythmia, ventricular extrasystoles. Bendamustine dosage: 75 MG/M2 DAYS 1 AND 2 OF 28-DAY CYCLE INTRAVENOUS. During the same period patient was treated with REVLIMID, COUMADIN, PROCARDIA, LEXAPRO, PRANDIN, XANAX. Patient was hospitalized. Bendamustine Side Effects Report #6010895-6
Physician from UNITED STATES reported Bendamustine side effect on Dec 10, 2008. Female patient, 47 years of age, weighting 187.4 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, blood magnesium decreased, confusional state, dehydration, diarrhoea, dyspnoea, epistaxis, hepatomegaly. Bendamustine dosage: 50 MG/M2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, RHINOCORT, ALLEGRA, ALBUTEROL, FLOVENT, MAXZIDE, COUMADIN. Patient was hospitalized.
Bendamustine Side Effects Report #6024191-4
Bendamustine side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 17, 2008. Female patient, 62 years of age, weighting 175.5 lb, was diagnosed with b-cell lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alopecia, anaemia, aortic arteriosclerosis, arteriosclerosis coronary artery, ascites, bacterial sepsis, blood alkaline phosphatase increased, blood bilirubin increased, blood glucose increased. Bendamustine dosage: 90 MG/M2 DAYS 1 + 4 INTRAVENOUS. During the same period patient was treated with BORTEZOMIB, RITUXAN, ZAROXOLYN, POTASSIUM CHLORIDE, MYLANTA, FLONASE, METOCLOPRAMIDE, LORTAB. Patient was hospitalized. Patient died on 11/10/2008.
Bendamustine Side Effects Report #6032681-3
Physician from UNITED STATES reported Bendamustine side effect on Dec 30, 2008. Male patient, 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: depressed level of consciousness, fluid intake reduced, hypophagia, ulcer haemorrhage, upper gastrointestinal haemorrhage. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized. Bendamustine Side Effects Report #6052841-5
Bendamustine side effect was reported by a Physician from UNITED STATES on Jan 15, 2009. Male patient, 55 years of age, weighting 212.5 lb, was diagnosed with lymphoma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, gastrointestinal ulcer haemorrhage, haematemesis, hypophagia, hypotension. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, CYMBALTA, LYRICA, MORPHINE, ZOLPIDEM, BACTRIM DS. Patient was hospitalized. Bendamustine Side Effects Report #6058086-7
Physician from UNITED STATES reported Bendamustine side effect on Jan 21, 2009. Male patient, 55 years of age, weighting 211.6 lb, was diagnosed with lymphoma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, duodenal ulcer, erosive duodenitis, gastritis erosive, hypotension, loss of consciousness, neutrophil count decreased, syncope. Bendamustine dosage: 194 MG DAYS 1 AND 2 INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB, CYMBALTA, LYRICA, MORPHINE, ZOLPIDEM, BACTRIM DS. Patient was hospitalized. Bendamustine Side Effects Report #6071764-9
Bendamustine side effect was reported by a Physician from JAPAN on Nov 12, 2008. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, aspartate aminotransferase increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood lactate dehydrogenase increased, blood urea increased, brain natriuretic peptide increased, c-reactive protein increased, cough. Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MECOBALAMIN, ADENOSINE, REBAMIPIDE. Patient was hospitalized.
Bendamustine Side Effects Report #6090773-7
Physician from UNITED STATES reported Bendamustine side effect on Feb 17, 2009. Male patient, 63 years of age, weighting 175.9 lb, was diagnosed with lymphoma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: diarrhoea, hypotension, oedema peripheral, tumour lysis syndrome. Bendamustine dosage: 180 MG QD INTRAVENOUS. During the same period patient was treated with BORTEZOMIB, RITUXIMAB, ZOFRAN, COMPAZINE, TYLENOL, MEPRAZOL, SIMVASTATIN. Patient was hospitalized. Bendamustine Side Effects Report #6091153-0
Bendamustine side effect was reported by a Physician from JAPAN on Feb 06, 2009. Male patient, 67 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune, cough, dizziness
, heart rate increased, immune system disorder, malaise, oropharyngeal pain, pyrexia, viral infection . Bendamustine dosage: 120 MG/KG FIRST THRU FOURTH CYCLE QD INTRAVENOUS. During the same period patient was treated with ACYCLOVIR, FLUCONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, MECOBALAMIN, ADENOSINE, REBAMIPIDE. Patient was hospitalized. Bendamustine Side Effects Report #6097316-2
Pharmacist from UNITED STATES reported Bendamustine side effect on Feb 26, 2009. Male patient, 45 years of age, was treated with Bendamustine. After drug was administered, patient experienced the following side effects: injection site pain. Bendamustine dosage: unknown.
Bendamustine Side Effects Report #6104696-8
Bendamustine side effect was reported by a Physician from UNITED STATES on Feb 24, 2009. Female patient, 52 years of age, weighting 165.0 lb, was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, biopsy bone marrow abnormal, cough, fatigue, lymphadenopathy, malaise, myalgia, neutrophil count decreased. Bendamustine dosage: 70 MG/M2 DAY 2, EVERY 35 DAYS X 5 CYCLES INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, METFORMIN, SIMVASTATIN, LASIX, NEXIUM, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #6106887-9
Physician from UNITED STATES reported Bendamustine side effect on Feb 26, 2009. Male patient, 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: atelectasis, dehydration, heart rate increased, lung infiltration, lymphoma
, malignant neoplasm progression, pleural effusion. Bendamustine dosage: 90 MG/M2 D1 ND D2 Q35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized. Bendamustine Side Effects Report #6106888-0
Bendamustine side effect was reported by a Health Professional from UNITED STATES on Feb 26, 2009. Female patient, 52 years of age, weighting 165.0 lb, was diagnosed with b-cell lymphoma, non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain upper, cough, fatigue, lymphadenopathy, myalgia, neutrophil count decreased, nocardiosis, organising pneumonia. Bendamustine dosage: 70 MG/M2 DAY 2, EVERY 35 DAYS X 5 CYCLES INTRAVENOUS. During the same period patient was treated with RITUXAN, VELCADE, METFORMIN, SIMVASTATIN, LASIX, NEXIUM, LEVAQUIN. Patient was hospitalized.
Bendamustine Side Effects Report #6112025-9
Physician from UNITED STATES reported Bendamustine side effect on Mar 04, 2009. Male patient, 62 years of age, weighting 160.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, anaemia, atelectasis, dehydration, hydronephrosis, lymphadenopathy, lymphoma
, myocardial ischaemia. Bendamustine dosage: 90 MG/M2 D1 AND D2 Q35 DAYS INTRAVENOUS. During the same period patient was treated with VELCADE, RITUXIMAB. Patient was hospitalized. Bendamustine Side Effects Report #4668602-5
Bendamustine side effect was reported by a Physician from on Nov 03, 2004. Male patient, 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, metastases to bone and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: jaw disorder, osteonecrosis
. Bendamustine dosage: 75 MG, QMO. During the same period patient was treated with PREDNISOLONE, ZOMETA. Bendamustine Side Effects Report #5039466-5
Physician from GERMANY reported Bendamustine side effect on Nov 03, 2004. Male patient, 88 years of age, weighting 127.9 lb, was diagnosed with plasmacytoma, multiple myeloma
and was treated with Bendamustine. After drug was administered, patient experienced the following side effects: dental treatment, gingival ulceration, osteonecrosis , periodontitis. Bendamustine dosage: 75 MG, QMO. During the same period patient was treated with PREDNISOLONE, ZOMETA.
Scroll to Bendamustine Side Effect Reports
67%